| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.04 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.04 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.092 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |